Pharmaceutical Blockbusters ($1B+ annual revenue)

Every drug with $1B+ annual disclosed revenue, ranked.

~150 rows ~45 KB CSV Updated quarterly Worldwide Free

Download

CSV ↓ JSON ↓

About this dataset

All currently-marketed drugs with disclosed annual revenue above $1 billion, sourced from quarterly SEC filings (10-K, 10-Q) and equivalent international filings.

Schema

ColumnDescriptionType
drug_idDrug identifierstring
brand_nameTrade namestring
company_nameManufacturerstring
annual_revenue_usdMost recent annual revenue (USD)number
fiscal_yearFiscal year of revenue figureinteger

Sources

SEC EDGAR (10-K / 10-Q), equivalent international filings.

Citation

APA

Drug Landscape. (2026). Pharmaceutical Blockbusters ($1B+ annual revenue) (Version 2026.05) [Data set]. Drug Landscape. https://druglandscape.com/datasets/blockbusters

BibTeX

@dataset{DrugLandscapeBlockbusters,
  author       = {Drug Landscape},
  title        = {Pharmaceutical Blockbusters ($1B+ annual revenue)},
  year         = {2026},
  version      = {2026.05},
  publisher    = {Drug Landscape},
  url          = {https://druglandscape.com/datasets/blockbusters},
  note         = {~150 rows; source: SEC EDGAR (10-K / 10-Q), equivalent international filings}
}

RIS

TY  - DATA
T1  - Pharmaceutical Blockbusters ($1B+ annual revenue)
AU  - Drug Landscape
PY  - 2026
ET  - 2026.05
PB  - Drug Landscape
UR  - https://druglandscape.com/datasets/blockbusters
ER  -

License

Free for any use including commercial, with attribution to Drug Landscape (druglandscape.com). Full terms in our editorial policy.

Other datasets